New Age Ventures

Type

Startup studio

Status

Active

Location

New York, United States

Total investments

31

Average round size

3M

Portfolio companies

19

Rounds per year

2.21

Lead investments

2

Follow on index

0.39

Exits

1

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologyCommercialSoftwareMobileArtificial IntelligenceHealth CareRoboticsMedical DeviceMedicalHardware

Investor highlights

Industry generalist
Yes
Industry focus
GeneralistHealthcareConsumer/RetailDeep TechAI/Big Data
Stage focus
SeedSeries APre-SeedSeries B
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
31
Lead investments
2
Exits
1
Rounds per year
2.21
Follow on index
0.39
Investments by industry
  • Health Care (10)
  • Software (9)
  • Medical Device (7)
  • Biotechnology (6)
  • Artificial Intelligence (6)
  • Show 42 more
Investments by region
  • United States (24)
  • Norway (1)
  • Israel (1)
  • Switzerland (1)
  • Canada (4)
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Avg. valuation at time of investment
3M
Group Appearance index
0.42
Avg. company exit year
21

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
ANNEX 01 Jan 2018 Retail, Manufacturing, Product Design Seed United States, New York, Brooklyn
Artract Medical Inc. 20 Aug 2021 Health Care, Medical Seed United States, California, Springville

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.